SPECIAL STORY FEED & ADDITIVE MAGAZINE November 2023 57 Today’s health and welfare achievements on poultry farms are highly impressive, but they’re rarely easy to maintain, especially in the face of the disruptive impact which a dysbiosis-based attack has on the gut microbiome of affected chicken. Devising effective control measures against this condition, which is widely recognised as one of the most harmful in relation to poultry production, has led researchers at Phileo by Lesaffre to focus on the role bacteria probiotics could play in protecting and preserving a healthy gut microbiome. In this context, Phileo by Lesaffre’s new generation probiotic, Microsaf®, has shown strong results in trials to assess its efficacy in countering a dysbiosis attack in chicken. Microsaf® is a unique association of Bacillus species, Bacillus amyloliquefaciens, Bacillus licheniformis, Bacillus pumilus, each of which was carefully selected to deliver improvements in feed efficiency, gut function, and microbiota. The probiotic is also designed to help boost overall growth performance in birds. The development of Microsaf® featured the use of Germination Optimization Technology - GO Technology®. This exclusive patented technology is equipped to make Bacillus spores ready to germinate, delivering probiotic benefits to birds more efficiently than non-GO processes. Comparing GO and non-GO technologies, in fact, has confirmed the role of GO Technology® in accelerating and synchronizing the germination of the three Microsaf® strains. Studies have shown that GO Technology®-primed Bacillus licheniform- “Countering dysbiosis in chicken to avoid reduced and uneven growth rates across flocks, issues that can have a severe impact on bird health and profitability, is a constant challenge for poultry producers.” DISABLING DYSBIOSIS IN ITS ATTACK ON CHICKEN PERFORMANCE AND PROFITS Dr. Alain Riggi, DVM Global Species Manager – Poultry Phileo by Lesaffre Dr. Ruth Raspoet Poultry R&D Manager Phileo by Lesaffre
RkJQdWJsaXNoZXIy MTUxNjkxNQ==